Select Medical (SEM) Expected to Announce Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) is expected to be posting its Q4 2025 results after the market closes on Thursday, February 19th. Analysts expect Select Medical to post earnings of $0.23 per share and revenue of $1.3641 billion for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, February 20, 2026 at 9:00 AM ET.

Select Medical Trading Up 2.0%

Shares of SEM stock opened at $16.22 on Thursday. Select Medical has a 1 year low of $11.65 and a 1 year high of $19.54. The firm has a market capitalization of $2.01 billion, a P/E ratio of 18.86, a price-to-earnings-growth ratio of 0.56 and a beta of 1.25. The firm’s fifty day simple moving average is $15.17 and its 200 day simple moving average is $13.95. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87.

Institutional Investors Weigh In On Select Medical

Several large investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP boosted its stake in shares of Select Medical by 4.2% during the third quarter. Dimensional Fund Advisors LP now owns 5,197,343 shares of the health services provider’s stock valued at $66,731,000 after purchasing an additional 207,951 shares during the period. State Street Corp raised its stake in Select Medical by 1.3% in the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after buying an additional 55,686 shares in the last quarter. 8 Knots Management LLC purchased a new stake in shares of Select Medical in the 2nd quarter worth about $26,568,000. Bank of America Corp DE increased its holdings in shares of Select Medical by 3.4% during the third quarter. Bank of America Corp DE now owns 1,673,302 shares of the health services provider’s stock valued at $21,485,000 after acquiring an additional 54,640 shares in the last quarter. Finally, Millennium Management LLC increased its holdings in Select Medical by 407.9% in the 3rd quarter. Millennium Management LLC now owns 1,590,339 shares of the health services provider’s stock worth $20,420,000 after buying an additional 1,277,233 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on SEM shares. Benchmark reaffirmed a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Mizuho set a $17.00 price objective on Select Medical in a report on Monday, November 3rd. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, January 21st. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $17.80.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.